dactinomycin has been researched along with 4-aminopyridine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Annunziato, L; Calì, G; Pannaccione, A; Scorziello, A; Secondo, A; Taglialatela, M | 1 |
Centurión, D; Cobos-Puc, LE; González-Hernández, A; Maassenvandenbrink, A; Muñoz-Islas, E; Ramírez-Rosas, MB; Sánchez-López, A; Villalón, CM | 1 |
2 other study(ies) available for dactinomycin and 4-aminopyridine
Article | Year |
---|---|
Nuclear factor-kappaB activation by reactive oxygen species mediates voltage-gated K+ current enhancement by neurotoxic beta-amyloid peptides in nerve growth factor-differentiated PC-12 cells and hippocampal neurones.
Topics: 4-Aminopyridine; Actin Cytoskeleton; Amyloid beta-Peptides; Animals; Blotting, Western; Calcium; Cell Differentiation; Cells, Cultured; Charybdotoxin; Chelating Agents; Cnidarian Venoms; Dactinomycin; Dose-Response Relationship, Drug; Drug Interactions; Egtazic Acid; Electric Stimulation; Embryo, Mammalian; Enzyme Activation; Enzyme Inhibitors; GAP-43 Protein; Hippocampus; Membrane Potentials; Nerve Growth Factor; Neurons; NF-kappa B; Patch-Clamp Techniques; PC12 Cells; Peptide Fragments; Peptides; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Protein Synthesis Inhibitors; Rats; Reactive Oxygen Species; Tetraethylammonium; Time Factors; Vitamin A | 2005 |
Pharmacological evidence that Ca²+ channels and, to a lesser extent, K+ channels mediate the relaxation of testosterone in the canine basilar artery.
Topics: 4-Aminopyridine; Adenine; Aminoglutethimide; Androgen Receptor Antagonists; Animals; Aromatase Inhibitors; Barium Compounds; Basilar Artery; Calcium Channel Blockers; Calcium Channels; Chlorides; Cycloheximide; Dactinomycin; Dogs; Enzyme Inhibitors; Flutamide; In Vitro Techniques; Male; Nifedipine; Nucleic Acid Synthesis Inhibitors; Oxadiazoles; Potassium Channel Blockers; Potassium Channels; Protein Synthesis Inhibitors; Quinoxalines; Testosterone; Vasodilation; Vasodilator Agents | 2011 |